SCHEMBL2831462

SCHEMBL2831462

O=C(NCc1ccccc1)Nc1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.77
RAB9A P51151 5/20 0.77
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
POLB P06746 1/20 0.77
MAOB P27338 1/20 0.77
HTT P42858 1/20 0.77
TP53 P04637 1/20 0.77
HPGD P15428 1/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
MAPT P10636 3/20 0.71
CA2 P00918 3/20 0.69
CA1 P00915 2/20 0.69
CA12 O43570 1/20 0.69
CA9 Q16790 1/20 0.69
ROCK2 O75116 1/20 0.69
ROCK1 Q13464 1/20 0.69
PTPN1 P18031 1/20 0.67
RORC P51449 1/20 0.64
KDM4E B2RXH2 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14025738 0.93 NPC1 (0.73) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL17000091 0.93 NPC1 (0.73) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL2704691 0.91 MAPT (0.66) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL20804368 0.90 NPC1 (0.65) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL4743393 0.89 NPC1 (0.73) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL22588922 0.89 NPC1 (0.68) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL10133206 0.89 ROCK2 (0.80) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL4744610 0.89 NPC1 (0.69) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL7420189 0.88 RAB9A (1.00) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL8177097 0.88 RAB9A (0.72) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227999-A1 Heterogeneous Supported Catalytic Carbamate Process MOLZAHN DAVID C 2008-09-18 US claimed
EP-1943214-A2 HETEROGENEOUS SUPPORTED CATALYTIC CARBAMATE PROCESS Dow Gloval Technologies Inc. (US) 2008-07-16 EP claimed
WO-2007015852-A2 HETEROGENEOUS SUPPORTED CATALYTIC CARBAMATE PROCESS DOW GLOBAL TECHNOLOGIES INC. (US) 2007-02-08 WO claimed
WO-2001007431-A2 BENZOTHIOPHENE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-02-01 WO claimed
EP-0805796-A1 CELL ADHESION INHIBITORS BIOGEN, INC. (US) 1997-11-12 EP claimed
WO-1996022966-A1 CELL ADHESION INHIBITORS BIOGEN, INC. (US) 1996-08-01 WO claimed
US-4699923-A N-benzoyl-N'-phenylureas and their use for insect control BASF AKTIENGESELLSCHAFT (DE) 1987-10-13 US claimed
EP-0056124-B1 N-BENZOYL N' PHENYLUREAS, PREPARATION AND USE THEREOF AS INSECTICIDES BASF Aktiengesellschaft (DE) 1984-06-27 EP claimed
JP-61093163-A None JP disclosed
CN-117886718-B Preparation method of high-selectivity asymmetric urea compound and asymmetric urea compound 内蒙古工业大学 2024-05-24 CN disclosed
CN-117886718-A Preparation method of high-selectivity asymmetric urea compound and asymmetric urea compound 内蒙古工业大学 2024-04-16 CN disclosed
US-20230348396-A1 HYDROXYBENZAMIDE DERIVATIVES AND METHODS OF USE IN TREATING DIABETES THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2023-11-02 US disclosed
EP-4217412-A1 WASTE MITIGATION METHODS AND MATERIALS Finite Research Ltd (GB) 2023-08-02 EP disclosed
CN-115353667-A Method and material for reducing waste 李蓁蓁 2022-11-18 CN disclosed
US-4520377-A COLOR FORMING LAYER COMO/SED OF ELECTRON DONATING COLORLESS DYE, ELECTRON ACCEPTING COMPOUND, NAPHTHOL UREA AND/OR URETHANE DERIVATIVE FUJI PHOTO FILM CO., LTD. (JP) 1985-05-28 US disclosed
US-4435567-A REACTING AN AMINE WITH AN N-CARBAMOYL BENZOIC ACID SULFIMIDE CHINOIN GYOGYSZER ES VESGYESZETI TERMEKEK GYARA R. T. (HU) 1984-03-06 US disclosed
US-4401717-A CONTAINING A CHROMOGEN, A PHENOL LAND A UREA OR CARBAMATE; THERMOGRAPHY FUJI PHOTO FILM CO., LTD. (JP) 1983-08-30 US disclosed
US-4220571-A Thermoplastic polyolefin composition and process for stabilizing polyolefins CIBA-GEIGY CORPORATION (US) 1980-09-02 US disclosed
US-4122090-A Cyclic esters of 3,4-dihydroxy-thiophene-1,1-dioxide compounds and 3,4-dihydroxy-cyclopentadienone compounds BASF AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-4089860-A Preparation of hydantoins by reacting esters of ethylene-1,2-dicarboxylic acids and ureas and thioureas BAYER AKTIENGESELLSCHAFT (DT) 1978-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227999-A1 Heterogeneous Supported Catalytic Carbamate Process CPS1, CAT, CA7 NPC1 3549/4885RAB9A 1660/4885MEN1 1538/4885
US-20230348396-A1 HYDROXYBENZAMIDE DERIVATIVES AND METHODS OF USE IN TREATING DIABETES HSPA5, IAPP, TFEB NPC1 2361/4885RAB9A 3298/4885MEN1 4857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.